QYUNS-B (02509) repurchased 44,000 shares for HKD 988,000 on January 21st.
Champion RealBiotech Group Ltd. (02509) announced that on January 21, 2026, the company spent HK$988,800 to repurchase 44,000 shares at a repurchase price of HK$22.08-22.50 per share.
QYUNS-B (02509) announces that on January 21, 2026, the company spent 988,800 Hong Kong dollars to repurchase 44,000 shares at a price of 22.08-22.50 Hong Kong dollars per share.
Related Articles

EASY SMART GP (02442): Restore public shareholding volume

US Stock Market Move | Winning a major contract from the US military, Intel Corporation (INTC.US) surged more than 6% at the opening.

EASY SMART GP (02442): Gong Zhaolong and Du Xiuwen have been appointed as independent non-executive directors.
EASY SMART GP (02442): Restore public shareholding volume

US Stock Market Move | Winning a major contract from the US military, Intel Corporation (INTC.US) surged more than 6% at the opening.

EASY SMART GP (02442): Gong Zhaolong and Du Xiuwen have been appointed as independent non-executive directors.

RECOMMEND

Moving Toward “7*24 Hour” Trading! NYSE Seeks Approval For “All‑Weather Blockchain Trading Platform”
21/01/2026

China Internet 2026: Under Pressure From ByteDance, Major Players Launch Full‑Scale Contest For AI Entry Points
21/01/2026

Hong Kong Equity Refinancing Opens Strong In 2026, Raising Over HKD 27 Billion
21/01/2026


